About IVD
IVD tests are helpful in diagnosis, screening, and disease management in humans and animals. These tests are usually performed in controlled environment, and they include blood analysis for the sign of infection and urine for the presence of glucose. The purpose of IVD test is not only to direct therapeutic effect but also to provide the health status of a patient. IVD plays an important role in supporting the decision making for clinical conditions. These advances have led to the development of point of care and self-test, which are easy and convenient for patients and medical professionals to use. The self-test include pregnancy test, blood glucose monitoring, cholesterol testing, infectious disease testing, and cardiac biomarker tests. IVD test can be performed in various settings, including clinical laboratory, a physician’s office, or at home.
Technavio's analysts forecast the IVD market in the US to grow at a CAGR of 5.45% over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the IVD market in the US for the period 2015–2019. The market can be divided into three segments: consumables, instruments, and services. To calculate the market size, the report considers the revenue generated from the three segments.
Technavio's report, the IVD Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.
Key Vendors
• Abbott Laboratories
• bioMérieux
• Danaher
• Roche Diagnostics
• Siemens Healthcare
Other Prominent Vendors
• A. Menarini Diagnostics
• ARKRAY
• Affymetrix
• Agilent Technologies
• Alere
• Axis-Shield
• Bio-Rad Laboratories
• Bruker BioSciences
• Cepheid
• Dako
• DiaSorin
• ELITech
• Eiken Chemical
• Fujirebio Diagnostics
• GE Healthcare
• Grifols
• Horiba
• Illumina
• Instrumentation Laboratory
• Johnson & Johnson
• Luminex
• Magellan Biosciences
• Nanosphere
• Nova Biomedical
• Nova Century Scientific
• PerkinElmer
• Phadia
• QIAGEN
• Quidel
• Quest Diagnostics
• Randox Laboratories
• Sysmex Hematology
• Tosoh
• Trinity Biotech
• Werfen Life Group
Market Driver
• Changes in Healthcare System
• For a full, detailed list, view our report
Market Challenge
• Regulatory and Reimbursement Issues
• For a full, detailed list, view our report
Market Trend
• Move toward Real-time Personalized Treatment
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. US Healthcare Reform
07. Reimbursement and Coverage: An Overview
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.2.1 Business Impact of Key Factors on Vendors
08.3 Five Forces Analysis
09. Market Segmentation by Application
10. Market Segmentation by Technique
11. Market Segmentation by Component
11.1 Consumables Market in US
11.1.1 Market Size and Forecast
11.2 Instruments Market in US
11.2.1 Market Size and Forecast
11.3 Services Market in US
11.3.1 Market Size and Forecast
12. Market Segmentation by End-users
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Abbott Diagnostics
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Geographical Presence
21.1.4 SWOT Analysis
21.2 BioMeriux
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Geographical Segmentation by Revenue 2013
21.2.5 Business Strategy
21.2.6 Recent Developments
21.2.7 SWOT Analysis
21.3 Danaher
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison 2012 and 2013
21.3.6 Segmentation by Geography
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 Roche Diagnostics
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation by Revenue 2014
21.4.4 Business Segmentation by Revenue 2013 and 2014
21.4.5 Geographical Segmentation by Revenue 2014
21.4.6 Business Strategy
21.4.7 Recent Developments
21.4.8 SWOT Analysis
21.5 Siemens Healthcare Diagnostics
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 SWOT Analysis
22. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Comparison of US Healthcare System Before and After Reforms
Exhibit 3: Reimbursement Perspectives of Healthcare Entities
Exhibit 4: IVD Market in US 2014-2019 ($ billions)
Exhibit 5: Segmentation of IVD Market in US by Application
Exhibit 6: Segmentation of IVD Market in US by Application 2014
Exhibit 7: Segmentation of IVD Market in US by Technique
Exhibit 8: Segmentation of IVD Market in US by Technique 2014
Exhibit 9: Segmentation of IVD Market in US by Component
Exhibit 10: Segmentation of IVD Market in US by Component 2014
Exhibit 11: Consumables Market in US 2014-2019 ($ billions)
Exhibit 12: Instruments Market in US 2014-2019 ($ billions)
Exhibit 13: Services Market in US 2014-2019 ($ billions)
Exhibit 14: Segmentation of IVD Market in US by End-users
Exhibit 15: Segmentation of IVD Market in US by End-users 2014
Exhibit 16: Abbott Laboratories: Key Takeaways
Exhibit 17: bioMérieux: Key Takeaways
Exhibit 18: Danaher: Key Takeaways
Exhibit 19: Roche Diagnostics: Key Takeaways
Exhibit 20: Siemens Healthcare: Key Takeaways
Exhibit 21: Abbott Diagnostics: Geographical Presence
Exhibit 22: bioMeriux: Business Segmentation by Revenue 2013
Exhibit 23: bioMeriux: Geographical Segmentation by Revenue 2013
Exhibit 24: Danaher: Business Segmentation
Exhibit 25: Danaher: Business Segmentation 2013
Exhibit 26: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 27: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 28: F. Hoffmann-La Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 29: F. Hoffmann-La Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
Exhibit 30: F. Hoffmann-La Roche Diagnostics: Geographical Segmentation by Revenue 2014
